Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Washington State offers a wide range of paid volunteering opportunities for both healthy participants and those looking for condition-specific clinical studies. Key centers in Seattle, Spokane, and Tacoma are actively recruiting participants, providing access to advanced medical treatments and innovative care solutions.
Filter
1
Filter results
Results: 1,593
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Washington D.C. DC, Durham NC, Columbus OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05843253
Phase2, Recruiting
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
for
Thoracoabdominal Aortic Aneurysm, Without Rupture
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT01874197
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for
Crohn's Disease
Location: Providence RI, Hamden CT, New York NY, Montreal,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06045754
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Boston MA, Providence RI, Stony Brook NY, Sherbrooke,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase3, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
for
Immunoglobulin Light Chain (AL) Amyloidosis
Location: Boston MA, New York NY, Miami FL, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06158854
Phase1, Phase2, Recruiting
Effectiveness of Aurix Therapy in Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Boston MA, Bristol CT, Middletown NY, Harris NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352454
Recruiting
A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas
for
Retroperitoneal Sarcoma, Liposarcoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06025747
Phase1, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: New Haven CT, New York NY, Hackensack NJ,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase1, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase3, Recruiting
Blue Light Cystoscopy With Cysview® Registry
for
Bladder Cancer
Location: New York NY, Baltimore MD, Washington D.C. DC,
Sponsor: Photocure
Sex: All
Age: 18+
Code: NCT02660645
Recruiting
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Location: Boston MA, Rochester NY, Chapel Hill NC, Detroit MI,
Sponsor: Opna Bio LLC
Sex: All
Age: 18+
Code: NCT06433947
Phase1, Recruiting
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
Kidney Precision Medicine Project
for
Acute Kidney Failure, Acute Kidney Insufficiency,
Location: Boston MA, New Haven CT, New York NY, Baltimore MD,